Journal of Chemical Technology and Applications

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Mini Review - Journal of Chemical Technology and Applications (2023) Volume 6, Issue 3

Advancements in nanotechnology for drug delivery: A chemical engineering perspective

Myles Bergeron*

Department of Chemical Engineering, University of Toronto Scarborough, Ontario, Canada

*Corresponding Author:
Myles Bergeron
Department of Chemical Engineering
University of Toronto Scarborough
Ontario, Canada
E-mail: myles.bergeron@utoronto.ca

Received: 14-Aug-2023, Manuscript No. AACTA-23-113083; Editor assigned: 16-Aug-2023, PreQC No. AACTA-23-113083(PQ); Reviewed: 25-Aug-2023, QC No. AACTA-23-113083; Revised: 28-Aug-2023, Manuscript No. AACTA-23-113083(R); Published: 18-Sep-2023, DOI: 10.35841/aacta-6.3.151

Citation: Bergeron M. Advancements in nanotechnology for drug delivery: A chemical engineering perspective. J Chem Tech App. 2023;6(3):151

Visit for more related articles at Journal of Chemical Technology and Applications

Abstract

Nanotechnology has emerged as a game-changer in the field of drug delivery, offering precise and targeted approaches to administering therapeutic agents. This article explores the recent advancements in nanotechnology from a chemical engineering perspective. It delves into the principles and methodologies that drive the design of nanocarriers for drug delivery, showcases notable innovations, and discusses the potential impact of these advancements on healthcare. Keywords: nanotechnology, drug delivery, chemical engineering, nanocarriers, targeted therapy, healthcare.

Keywords

Nanotechnology, Drug Delivery, Chemical Engineering, Nanocarriers, Targeted Therapy, Healthcare.

Introduction

The field of drug delivery has witnessed remarkable advancements over the years, and one of the most revolutionary developments has been the integration of nanotechnology. Nanotechnology in drug delivery involves the design, development, and utilization of nanoscale materials and structures to enhance the delivery of therapeutic agents to specific sites within the body. This article provides an overview of recent breakthroughs in nanotechnology for drug delivery, emphasizing the chemical engineering principles that underpin these innovations [1].

Nanotechnology in Drug Delivery: A Brief Overview: Nanotechnology has opened new avenues for drug delivery due to its unique properties at the nanoscale. Nanosized carriers, often referred to as nanocarriers, offer several advantages, including increased drug solubility, improved pharmacokinetics, and targeted delivery to diseased tissues [2]. Key components of nanocarriers include nanoparticles, liposomes, micelles, dendrimers, and nanotubes, each with distinct attributes that can be tailored for specific applications [3].

Chemical Engineering Principles in Nanotechnology

Chemical engineering plays a pivotal role in the development of nanocarriers for drug delivery [4]. Key principles include:

Material Selection: Chemical engineers choose materials based on their compatibility with drug compounds, biocompatibility, and their ability to encapsulate and release drugs efficiently.

Synthesis and Fabrication: Chemical engineering techniques are employed to synthesize nanoparticles and nanoscale materials with precise control over size, shape, and surface properties.

Surface Functionalization: Nanocarriers can be functionalized with targeting ligands, antibodies, or responsive polymers to enhance specificity and control drug release.

Scale-up and Manufacturing: Chemical engineers ensure that nanocarrier production can be scaled up for commercial use while maintaining quality and consistency.

Recent Innovations in Nanotechnology for Drug Delivery

Several noteworthy advancements exemplify the transformative potential of nanotechnology in drug delivery:

Personalized Medicine: Nanocarriers can be customized to carry specific drugs for individualized treatment regimens, improving therapeutic outcomes.

Cancer Targeting: Targeted nanoparticles can selectively deliver anticancer drugs to tumor cells, reducing side effects on healthy tissues.

RNA-Based Therapeutics: Nanotechnology facilitates the delivery of RNA-based therapeutics, such as mRNA vaccines and siRNA for gene silencing.

Brain Drug Delivery: Nanoparticles can cross the blood-brain barrier, opening new possibilities for treating neurological disorders.

Challenges and Future Directions

Despite the exciting progress in nanotechnology for drug delivery, several challenges remain. These include regulatory hurdles, manufacturing scalability, and long-term safety assessments. Future research in this field is likely to focus on improving the clinical translation of nanocarriers, exploring new materials, and enhancing drug-loading capacities [5].

Conclusion

Advancements in nanotechnology are reshaping the landscape of drug delivery, offering precise, targeted, and efficient approaches to administering therapeutic agents. As the field continues to evolve, chemical engineers are at the forefront, leveraging their expertise to design and optimize nanocarriers that hold the promise of revolutionizing healthcare. These innovations have the potential to enhance drug efficacy, minimize side effects, and ultimately improve patient outcomes, ushering in a new era of personalized medicine.

References

  1. Cheng YJ, Wolkenhauer M, Bumbu GG, et al. A Facile Route to Reassemble Titania Nanoparticles Into Ordered Chain-like Networks on Substrate. Macromol Rapid Commun. 2012;33(3):218-24.

    2. Indexed at, Google Scholar, Cross Ref

  2. Huang Q, Yu H, Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci. 2010;75(1):R50-7.

    3. Indexed at, Google Scholar, Cross Ref

  3. Venkatasubbu GD, Baskar R, Anusuya T, et al. Toxicity mechanism of titanium dioxide and zinc oxide nanoparticles against food pathogens. Colloids Surf B. 2016;148:600-6.

    4. Indexed at, Google Scholar, Cross Ref

  4. Davis JL, Paris HL, Beals JW, et al. Liposomal-encapsulated ascorbic acid: Influence on vitamin C bioavailability and capacity to protect against ischemia–reperfusion injury. Nutr Metab Insights. 2016:NMI-S39764.

    5. Indexed at, Google Scholar, Cross Ref

  5. Park JH, von Maltzahn G, Ruoslahti E, et al. Supporting Information for: Micellar Hybrid Nanoparticles for Simultaneous Magneto-Fluorescent Imaging and Drug Delivery. 2008.

    6. Indexed at, Google Scholar, Cross Ref

Get the App